FB Pixel no scriptRecent | KrASIA
MENU
KrASIA

Most Recent

  • A Hong Kong listing rarely boosts Chinese firms’ valuations, but Hengrui Pharmaceuticals might still take the plunge.

    News

    Hengrui weighs Hong Kong IPO to drive the next phase of global expansion

    4 mins read